Local versus Global Market Shaping with Oliver Sabot

About this episode

Episode quotes

Click a timestamp to jump straight to it in the player.

• Why funding alone isn’t enough

  17:14

  I see it again and again that, as they move into new sectors, that's the last thing that the community thinks of, right? It will push hard on the funding, it will push hard on the, you know, advanced market commitments or new research and so forth, but it doesn't invest comparatively tiny amounts of money in the quarterback role because it's very unsexy, right? Like, you're not gonna do a press release on that, but it's immensely important.

• The trap of one-tool thinking in market shaping

  23:29

  Different actors start to have strong perspectives on one aspect of the market shaping toolkit. So some people say advanced market commitments are great. I agree. I think advanced market commitments can be an amazing tool in some cases for some products, for some markets. But you don't want to be a hammer looking for a nail saying, like, the only thing that should ever be done is advanced market commitment, then you're only relevant to the 10% of the places where that's warranted.

• On acting like a private company to save lives

  05:18

  So, essentially, what we did is, how can we, a group of social actors, how can we act like a drug company would, right? How can we actually work with suppliers of this, make it into attractive packaging, actually, sort of, launch it as a product and invest as a company would in the marketing and sales, down the chain through distributors and wholesalers. What are their incentives? What profit margins do they need to charge in order for this to be an attractive business for them down to the drug shops?